Key result
Cardiac fibrosis is a frequent occurrence in patients with diabetes mellitus that predisposes to heart failure, suggesting bioimaging and biomarkers may become clinically useful tools.
Answers are grounded in this paper and cite their sources.
Cardiac fibrosis is a major factor predisposing diabetic patients to heart failure and arrhythmias, highlighting the potential clinical utility of bioimaging and biomarkers.
B oth type 1 and type 2 diabetes mellitus (DM) are associated with a significant increase in cardiovascular risk.2][3] The level at which blood pressure should be controlled also is controversial. 4Thus, there may be a need to focus on new therapeutic targets if we are to reduce cardiovascular risk in patients with either type 1 or type 2 DM.Cardiac and large arteries fibrosis is a frequent occurrence in patients with DM and one of the major factors predisposing to the development of heart failure (HF).Cardiac fibrosis is the consequence of extracellular cardiac matrix remodeling resulting from pathological processes, including ischemia; stretch; inflammation; and specifically in DM, oxidative stress, advanced glycation end products, and several neurohormonal mediators.Cardiac fibrosis may cause myocyte slippage, tissue heterogeneity and dyssynchrony, ventricular dilatation, and contractile dysfunction.Myocardial fibrosis alters myocardial compliance, and associated fibrosis-related large artery stiffness may predispose to diastolic dysfunction and HF with a preserved left ventricular ejection fraction.Cardiac fibrosis also may result in alteration of gap junctions and predispose to arrhythmias and sudden cardiac death. 5Bioimaging and biomarkers of cardiac fibrosis, therefore, may become clinically useful tools, particularly given the potential for cardioprotective and cardioreparative pharmacological strategies. 6,
No takes yet. Share an insight, caveat, or question.
Pitt et al. (2012) conducted a review in Diabetes mellitus and myocardial fibrosis. Cardiac fibrosis is a frequent occurrence in patients with diabetes mellitus that predisposes to heart failure, suggesting bioimaging and biomarkers may become clinically useful tools.
Synapse has enriched 10 related papers. Consider them for comparative context: